Is dasatinib a chemotherapy drug?

Dasatinib (Dasatinib) is not a chemotherapy drug in the traditional sense, but a targeted therapy drug, classified as a BCR-ABL tyrosine kinase inhibitor (TKI), used to treat certain types of blood or bone marrow cancers. It is used to treat various stages of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (Ph+CML) or acute lymphoblastic leukemia (Ph+ALL) in adults and children. Dasatinib is taken as an oral tablet, and for some patients, dasatinib can be used in addition to chemotherapy.

Different from traditional chemotherapy drugs, chemotherapy usually suppresses cancer cells through extensive suppression of rapidly stimulating cells. This approach not only affects tumor cells, but also causes damage to normal cells, leading to side effects. Dasatinib targets specific biomarkers, such as the BCR-ABL fusion protein, an abnormal tyrosine kinase found in most CML patients. By inhibiting the activity of this specific kinase, dasatinib effectively blocks the growth and spread of cancer cells.

The use of dasatinib has been proven to significantly improve the remission rate of CML patients in the chronic phase and also shows good efficacy in patients with accelerated and acute phase CML. Because of its specific mechanism of action, patients typically experience fewer side effects from traditional chemotherapy when taking dasatinib. For example, patients may not experience symptoms such as severe nausea and vomiting. Of course, this does not mean that dasatinib has no side effects. It may still cause adverse reactions such as thrombocytopenia, abnormal liver function, and edema.

In clinical application, the dosage of dasatinib varies according to the patient's specific condition. In patients with chronic phase CML, 100 mg once daily is usually recommended, while for patients in accelerated phase or other more complex types, the dose can be increased to 140 mg daily. Pediatric patients require reasonable adjustments based on body weight. It is crucial for patients to accurately follow their doctor's medication recommendations to ensure maximum effectiveness of treatment.